Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
Clinical trial NCT04317534 · RECRUITING
Trial details
- NCT number
- NCT04317534
- Sponsor
- Greg Durm, MD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-05
- Primary completion
- 2027-04-08
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.